AR077238A1 - Composiciones para el cuidado bucal. uso de un polimero para fabricar la composicion - Google Patents

Composiciones para el cuidado bucal. uso de un polimero para fabricar la composicion

Info

Publication number
AR077238A1
AR077238A1 ARP100102264A ARP100102264A AR077238A1 AR 077238 A1 AR077238 A1 AR 077238A1 AR P100102264 A ARP100102264 A AR P100102264A AR P100102264 A ARP100102264 A AR P100102264A AR 077238 A1 AR077238 A1 AR 077238A1
Authority
AR
Argentina
Prior art keywords
polymer
composition
dye
oral care
care according
Prior art date
Application number
ARP100102264A
Other languages
English (en)
Inventor
Carole Jane Philpotts
Andrew Joiner
Sheng Meng
Qingsheng Tao
Jinfang Wang
Stephen Norman Batchelor
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of AR077238A1 publication Critical patent/AR077238A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
    • C12Q2521/331—Methylation site specific nuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2523/00—Reactions characterised by treatment of reaction samples
    • C12Q2523/10—Characterised by chemical treatment
    • C12Q2523/125—Bisulfite(s)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Abstract

Reivindicacion 1: Una composicion para el cuidado bucal que comprende un polímero colorante, para modificar el color de los dientes. Reivindicacion 3: Una composicion para el cuidado bucal que comprende un polímero colorante, donde la funcionalidad del colorante está covalentemente unida al resto del polímero. Reivindicacion 5: Una composicion para el cuidado bucal de acuerdo con la reivindicacion 3 o 4, caracterizada porque el polímero colorante presenta la formula: (cadena de polímero)-(Y-colorante)x en la cual Y es un enlace entre el colorante y la cadena de polímero y x es el numero de partes de colorante asociadas a una molécula de polímero dada. Reivindicacion 6: Una composicion para el cuidado bucal de acuerdo con la reivindicacion 5, caracterizada porque Y es típicamente un grupo puente orgánico que conecta covalentemente un anillo aromático de una parte de colorante con la cadena de polímero y tiene entre 1 y 8 átomos, y el átomo se selecciona entre: C, N, O y S. Reivindicacion 7: Una composicion para el cuidado bucal de acuerdo con cualquiera de las reivindicaciones anteriores, caracterizada porque el polímero colorante comprende partes de antraquinona. Reivindicacion 10: Una composicion para el cuidado bucal de acuerdo con cualquiera de las reivindicaciones anteriores, que comprende agua, espesante, surfactante y abrasivo.
ARP100102264A 2009-06-26 2010-06-25 Composiciones para el cuidado bucal. uso de un polimero para fabricar la composicion AR077238A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09163934 2009-06-26

Publications (1)

Publication Number Publication Date
AR077238A1 true AR077238A1 (es) 2011-08-10

Family

ID=42470871

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100102264A AR077238A1 (es) 2009-06-26 2010-06-25 Composiciones para el cuidado bucal. uso de un polimero para fabricar la composicion

Country Status (6)

Country Link
US (2) US20120184447A1 (es)
EP (2) EP2966181B1 (es)
JP (1) JP6013910B2 (es)
AR (1) AR077238A1 (es)
ES (1) ES2669439T3 (es)
WO (1) WO2010149782A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2994545B1 (en) 2013-05-10 2019-03-20 University Of Southern California Dna methylation biomarkers for bladder cancer
CN113186288A (zh) * 2015-02-24 2021-07-30 兹莫研究公司 测定dna甲基化的分析法和癌症的dna甲基化标记
GB201511152D0 (en) 2015-06-24 2015-08-05 Ucl Business Plc Method of diagnosing bladder cancer
AU2018269030A1 (en) 2017-05-18 2019-10-17 Genomic Health, Inc. DNA methylation and mutational analysis methods for bladder cancer surveillance
US20210172029A1 (en) * 2018-07-11 2021-06-10 Stichting Vumc Urine dna methylation markers for bladder cancer

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585481A (en) 1987-09-21 1996-12-17 Gen-Probe Incorporated Linking reagents for nucleotide probes
US5457183A (en) 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5245022A (en) 1990-08-03 1993-09-14 Sterling Drug, Inc. Exonuclease resistant terminally substituted oligonucleotides
US5565552A (en) 1992-01-21 1996-10-15 Pharmacyclics, Inc. Method of expanded porphyrin-oligonucleotide conjugate synthesis
US5574142A (en) 1992-12-15 1996-11-12 Microprobe Corporation Peptide linkers for improved oligonucleotide delivery
SE501439C2 (sv) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Sätt och anordning för analys av polynukleotidsekvenser
JPH09506253A (ja) 1993-11-30 1997-06-24 マクギル・ユニヴァーシティ Ｄｎａメチルトランスフェラーゼの阻害
US5597696A (en) 1994-07-18 1997-01-28 Becton Dickinson And Company Covalent cyanine dye oligonucleotide conjugates
US5514758A (en) 1994-09-30 1996-05-07 The Goodyear Tire & Rubber Company Process for making latex for high performance masking tape
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
AU7829398A (en) 1997-06-09 1998-12-30 University Of Southern California A cancer diagnostic method based upon dna methylation differences
DE19754482A1 (de) 1997-11-27 1999-07-01 Epigenomics Gmbh Verfahren zur Herstellung komplexer DNA-Methylierungs-Fingerabdrücke
US7700324B1 (en) 1998-11-03 2010-04-20 The Johns Hopkins University School Of Medicine Methylated CpG island amplification (MCA)
US5958773A (en) 1998-12-17 1999-09-28 Isis Pharmaceuticals Inc. Antisense modulation of AKT-1 expression
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
DK1291427T3 (da) * 2000-06-01 2007-04-10 Otsuka Pharma Co Ltd Fremgangsmåde til påvisning og kvantificering af humane P450-molekylspecies og probe og kit til denne fremgangsmåde
EA007028B1 (ru) * 2000-09-01 2006-06-30 Эпигеномикс Аг Метод определения степени метилирования специфических цитозинов в геномной днк в контексте последовательности 5'-cpg-3'
US20050064401A1 (en) * 2000-09-01 2005-03-24 Alexander Olek Diagnosis of illnesses or predisposition to certain illnesses
US7473767B2 (en) 2001-07-03 2009-01-06 The Institute For Systems Biology Methods for detection and quantification of analytes in complex mixtures
USH2220H1 (en) * 2001-08-10 2008-07-01 Snp Consortium Identification and mapping of single nucleotide polymorphisms in the human genome
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
US7217807B2 (en) * 2002-11-26 2007-05-15 Rosetta Genomics Ltd Bioinformatically detectable group of novel HIV regulatory genes and uses thereof
US20040265833A1 (en) * 2003-06-23 2004-12-30 Cathy Lofton-Day Methods and nucleic acids for the analysis of colorectal cell proliferative disorders
WO2006004597A2 (en) * 2004-06-01 2006-01-12 University Of Southern California Association of breast cancer dna methylation profiles with hormone receptor status and response to tamoxifen
US20080003609A1 (en) * 2006-05-10 2008-01-03 The Cleveland Clinic Foundation Method of detecting bladder urothelial carcinoma
ATE549418T1 (de) * 2007-01-19 2012-03-15 Epigenomics Ag Verfahren und nukleinsäuren zur analyse proliferativer zellerkrankungen
CN101353695B (zh) * 2007-07-23 2013-05-01 上海市肿瘤研究所 尿沉淀dna甲基化谱式分析诊断膀胱癌的方法和试剂盒
PL2198042T3 (pl) * 2007-09-17 2017-05-31 Mdxhealth Sa Nowe markery do wykrywania raka pęcherza moczowego
CN101878315A (zh) * 2007-11-30 2010-11-03 基因特力株式会社 使用膀胱癌特异性甲基化标记基因的膀胱癌诊断试剂盒和芯片

Also Published As

Publication number Publication date
EP2966181A1 (en) 2016-01-13
US20150152509A1 (en) 2015-06-04
JP2012530508A (ja) 2012-12-06
WO2010149782A1 (en) 2010-12-29
JP6013910B2 (ja) 2016-10-25
ES2669439T3 (es) 2018-05-25
EP2966181B1 (en) 2018-02-14
EP2446055A1 (en) 2012-05-02
US20120184447A1 (en) 2012-07-19

Similar Documents

Publication Publication Date Title
CO6290631A2 (es) Composición oral que contiene amino ácidos y un agente blanqueador
AR077238A1 (es) Composiciones para el cuidado bucal. uso de un polimero para fabricar la composicion
AR080814A1 (es) Composicion para el cuidado bucal
BR112012015171A2 (pt) "kit contendo corantes fotossensibilizantes".
AR050946A1 (es) Composiciones para el tratamiento de la ropa.
AR080507A1 (es) Composiciones detergentes liquidas que comprenden un gelificante diamido y los procesos para elaborarlas
BRPI0910081A2 (pt) Processo de clareamento das fibras queratínicas humanas, processo de coloração das fibras queratínicas humanas e dispositivos com vários compartimentos
CL2012000716A1 (es) Metodo no terapeutico para la desinfeccion de una superficie que comprende i) aplicar una composicion que comprende eugenol, terpineol, timol y un portador, y ii) enjuagarla con un solvente adecuado; composicion antimicrobiana; y uso no terapeutico de la composicion para la higiene mejorada de manos, bucal y de superficies duras.
GT200600164A (es) Derivados de dihidrobenzofuranos y usos de los mismos
GT200500119A (es) Derivados de tetraazabenzo [e] azuleno y sus analogos
MX2009012393A (es) Tintes de trifenodioxazina.
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
CL2008000895A1 (es) Composición para el cuidado oral que comprende un aminoácido fundamental; una fracción de partículas pequeñas y un agente antimicrobiano y su uso para reducir o prevenir las caries dentales, lesiones del esmalte, desmineralización, hipersensibilidad dental, gingivitis, entre otras.
AR089390A1 (es) Composiciones que comprenden galatos y galamidas
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
NI200900147A (es) Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
CR20110062A (es) Nuevos derivados de acilaminobenzamida
CL2018000005A1 (es) Composición para el cuidado bucal que comprende silicato de calcio.
UY31712A1 (es) Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen
GT200300108A (es) Derivados de benzoxazina y usos de los mismos
NO20073026L (no) 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav
HN2010000330A (es) DERIVADOS DE INDOL-2-ONA DISUSTITUIDOS EN 3 y SU PREPARACION
GT200500383A (es) Sulfonamido-macrociclos y sus sales, una composicion farmaceutica que comprende estos compuestos, un metodo de preparacion y el uso de los mismos
ECSP088603A (es) Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4
CO6341629A2 (es) Derivados de benzotiofeno alkanol piperazina y su uso como antidepresivos

Legal Events

Date Code Title Description
FG Grant, registration